Editas Medicine (EDIT) Retained Earnings (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Retained Earnings data on file, last reported at -$1.6 billion in Q3 2025.

• On a quarterly basis, Retained Earnings fell 12.43% year-over-year to -$1.6 billion in Q3 2025; TTM through Sep 2025 was -$1.6 billion, a 12.43% decrease from a year earlier, with the FY2024 full-year figure at -$1.5 billion, down 741737.88% from the prior year.
• Retained Earnings for Q3 2025 stood at -$1.6 billion, roughly flat from -$1.6 billion in the prior quarter.
• Over the last five years, Retained Earnings for EDIT reached as high as $198000.0 in Q4 2023 and fell as low as -$1.6 billion in Q3 2025.
• Historically, Retained Earnings has averaged -$720.8 million across 5 years, with a median of -$857.7 million in 2021.
• Across the five-year window, Retained Earnings slumped 1864463.04% in 2021 and surged 105.5% in 2023, its largest moves.
• Year by year, Retained Earnings stood at -$857.7 million in 2021, then jumped by 99.58% to -$3.6 million in 2022, then surged by 105.5% to $198000.0 in 2023, then plunged by 741737.88% to -$1.5 billion in 2024, then decreased by 8.96% to -$1.6 billion in 2025.
• Per Business Quant data, the three most recent Retained Earnings figures were -$1.6 billion in Q3 2025, -$1.6 billion in Q2 2025, and -$1.5 billion in Q1 2025.